Principal Financial Group Inc. Has $328,000 Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)

Principal Financial Group Inc. lifted its stake in MiMedx Group, Inc. (NASDAQ:MDXG) by 6.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 55,495 shares of the company’s stock after acquiring an additional 3,292 shares during the quarter. Principal Financial Group Inc.’s holdings in MiMedx Group were worth $328,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of the stock. ProShare Advisors LLC increased its position in MiMedx Group by 8.5% during the first quarter. ProShare Advisors LLC now owns 20,735 shares of the company’s stock worth $160,000 after buying an additional 1,631 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in MiMedx Group by 1.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock worth $1,082,000 after buying an additional 1,822 shares during the last quarter. Hsbc Holdings PLC increased its position in MiMedx Group by 7.3% during the second quarter. Hsbc Holdings PLC now owns 34,343 shares of the company’s stock worth $233,000 after buying an additional 2,329 shares during the last quarter. The Manufacturers Life Insurance Company increased its position in MiMedx Group by 7.6% during the second quarter. The Manufacturers Life Insurance Company now owns 45,623 shares of the company’s stock worth $316,000 after buying an additional 3,222 shares during the last quarter. Finally, Marshall Wace LLP increased its position in MiMedx Group by 1.1% during the second quarter. Marshall Wace LLP now owns 298,818 shares of the company’s stock worth $2,071,000 after buying an additional 3,223 shares during the last quarter. 79.15% of the stock is owned by institutional investors and hedge funds.

MiMedx Group Stock Down 0.2 %

MDXG stock opened at $9.20 on Monday. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.10 and a quick ratio of 3.53. MiMedx Group, Inc. has a 52-week low of $5.47 and a 52-week high of $9.49. The company has a 50-day moving average of $6.60 and a two-hundred day moving average of $6.84. The stock has a market capitalization of $1.35 billion, a price-to-earnings ratio of 16.73 and a beta of 1.94.

Analyst Upgrades and Downgrades

Several research firms have commented on MDXG. Craig Hallum lowered their target price on shares of MiMedx Group from $14.00 to $12.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. StockNews.com cut shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $11.00 price target on shares of MiMedx Group in a report on Thursday, August 1st. Six analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $12.00.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.